Inhibikase Therapeutics Inc
NASDAQ:IKT 3:43:49 PM EDT
| Market Cap (Intraday) | 19.03M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.84 |
| 50-Day MA | $0.91 |
| 200-Day MA | $1.44 |
Inhibikase Therapeutics Inc Stock, NASDAQ:IKT
3350 Riverwood Parkway, Suite 1900, Atlanta, Georgia 30339
United States of America
Phone: +1.678.392.3419
Number of Employees: 6
Description
Inhibikase Therapeutics, Inc. provides infectious disease treatments. It develops small molecule platform for treating both bacterial and viral infectious diseases. It operates through RAMPâ„¢ Drug Innovation Engine technology. The company was founded by Milton H. Werner in September 2008 and is headquartered in Atlanta, GA.